Latest News Archive
Please select Category, Year, and then Month to display items
27 December 2019
|
Story Dr Cindé Greyling
|
Photo Supplied
KovsieInnovation at the UFS is bridging the gap between industry and academics with a powerful force. For too long, research remained an academic pursuit, with many innovative ideas stuck between the pages of a thesis – only to come alive during exclusive, short-lived conference proceeds.
KovsieInnovation
Recently, Gerard Verhoef, Director in the Directorate: Research Development (DRD), and his team from KovsieInnovation finalised their Innovation and Commercialisation Strategy in order to create a structured pathway for good ideas. The primary objective of KovsieInnovation – the UFS Innovation and Entrepreneurship Office – is to achieve sustainable growth in third-stream income from innovative research activities stemming from the UFS. “Potential successful ideas must be feasible, viable, and sustainable, and we formulated an eight-step plan to facilitate this,” Verhoef explains. Ultimately, the DRD wants to attract new and continuous research as a renowned academic knowledge partner that can foster, drive, and successfully commercialise innovative research activities; and in doing so, foster an entrepreneurial culture at the UFS.
Liquid Culture
One such success story is the development of Liquid Culture into a business of choice, supplying liquid yeast to breweries and bakeries. Christopher Rothmann and Dr Errol Cason are the driving forces behind this company that produces their sought-after and stable yeast product in the Department of Microbiology, Biochemistry and Food Biotechnology at the UFS. With world-class equipment and laboratories, they house one of the largest yeast-culture collections in the world.
Both Rothman and Dr Cason were home brewers for many years before starting to produce commercial batches. They believe it would not have been possible without the help of KovsieInnovation. This project was also one of the finalists in the National Entrepreneurship Intervarsity.
Christo Strydom Nutrition (CSN)
Another innovative way in which the UFS generates third-stream income via the DRD, is by partnering with already successful commercial products. One such example is the recent successful royalty agreement with CSN. With this transaction, the university unlocked its brand potential to the benefit of both the industry partner and the UFS. Quality assurance remains the key success factor for deals like this.
Invitation to International Cardiothoracic congress
2011-06-01
Our Faculty of Health Sciences is pleased to announce the European Association for Cardiothoracic Surgeons Academy (EACTS) and Hannes Meyer Cardiothoracic Surgery Registrar Symposium, which will be taking place on our Bloemfontein Campus from 3 to 5 June 2011.
The congress first started in 2004 as the Hannes Meyer Registrar Congress, which was jointly hosted by the UFS and the Society of Cardiothoracic Surgeons of South Africa. This event was hosted on our Bloemfontein Campus annually, except in 2009, when the University of Cape Town was the host.
The focus of this year’s symposium is new techniques in perfusion and surgery, with specific emphasis on research methodology, inflammatory lung disease and cardiac surgery in children and adults, which can be performed without the aid of a heart-lung machine in developing countries.
Prof. Francis Smit, Head of the Department of Cardiothoracic Surgery in the Faculty of Health Sciences, says EACTS identified the UFS as the Sub-Saharan training unit they will support in terms of training. The first of these symposiums was accordingly hosted in 2010.
This year’s symposium will be attended by approximately 70 delegates from cardiothoracic units from across South Africa and 10 doctors from 6 African countries, as well as 30 perfusion technologists.
“We are fulfilling a leadership role in Africa and South Africa with this course,” says Prof. Smit.
Several international visitors will be present, like Prof. Paul Sergeant and Prof. Marko Turina, two previous EACTS presidents and Prof. Charles Yankah, a Ghanaian Cardiothoracic Surgeon from the Charite Medical University in Berlin. The current president of the European Board of Cardiovascular Perfusion (EBCP), Mr Frank Merkle, will also be one of three international speakers delivering lectures on perfusion technology.
You are invited to attend the conference on the following dates:
Date: 3 - 5 June 2011
Time: 09:00
Venue: Faculty of Health Sciences in the Francois Retief Building on our Bloemfontein Campus